NDLI: Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.

Please wait, while we are loading the content...

Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.

Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.

Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.

Extracellular mitochondrial ATP, suramin, and autism?

Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism.

Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.

Dosing and antipyretic efficacy of oral acetaminophen in children.

Efficacy and speed of onset of pain relief of fast-dissolving paracetamol on postsurgical dental pain: two randomized, single-dose, double-blind, placebo-controlled clinical studies.

Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.

Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.

Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.

A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).

Efficacy and safety of morning versus evening dose of controlled-release simvastatin tablets in patients with hyperlipidemia: a randomized, double-blind, multicenter phase III trial.

Cancer chemotherapy: a rapidly moving train.

Targeted therapies in oncology come of age.

Targeted therapy in chronic lymphocytic leukemia: past, present, and future.

Discovery of novel drugs for promising targets.

Epidermal growth factor receptor: pathway, therapies, and pipeline.

Real-world application of the roadmap model in chronic hepatitis B patients with telbivudine therapy.

Year: 2013 Volume: 35 Issue: 8

Year: 2013 Volume: 35 Issue: 7

Year: 2013 Volume: 35 Issue: 6

Year: 2013 Volume: 35 Issue: 5

Year: 2013 Volume: 35 Issue: 4

Year: 2013 Volume: 35 Issue: 3

Year: 2013 Volume: 35 Issue: 2

Year: 2013 Volume: 35 Issue: 1

Year: 2012 Volume: 34

Year: 2011 Volume: 33

Year: 2010 Volume: 32

Year: 2009 Volume: 31

Year: 2008 Volume: 30

Year: 2008 Volume: 30 Spec No

Year: 2008 Volume: 30 Pt 2

Year: 2007 Volume: 29

Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Seifert, Charles F. Wiltrout, Tara R.
Description	Author Affiliation: Seifert CF ( School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, Texas. Electronic address: charles.seifert@ttuhsc.edu.)
Abstract	BACKGROUND: Several previous studies have reported both an association between selective serotonin reuptake inhibitors (SSRI) and decreased bone mineral density and increased fractures, but no previous studies have specifically evaluated bone health in young adults who have a history of SSRI use. OBJECTIVE: The purpose was to characterize the effect SSRI use in early adulthood on bone mineral density. METHODS: A cross-sectional study was conducted on subjects who voluntarily responded to recruitment methods for the study. Young adults aged 18 to 25 years who were currently or had previously taken an SSRI for a minimum of 3 consecutive months were included in the study. A subject interview was conducted on each patient to collect background information. Each subject's calcaneal bone mineral density was then measured with an ultrasonometer. RESULTS: Complete data were collected on 51 subjects. The median duration of SSRI use was 24 ± 54 months. A significant negative correlation was observed between SSRI duration and calcaneal ultrasound T-score (r = -0.53, P < 0.001) which was unchanged in depressed subjects. Subjects on continuous SSRIs for >24 months had a significantly lower median T-score (0.30 ± 0.93) than subjects taking SSRIs for ≤ 24 months (0.90 ± 0.81; P = 0.0010). CONCLUSIONS: In this young relatively healthy population who were following most of the recommendations to improve bone health, a significant negative correlation was observed between the duration of SSRI use and bone mineral density. Subjects who were on SSRIs for longer than 24 months had a significantly lower T-score. Further large scale longitudinal studies are needed in this younger population to determine the effects of chronic SSRI use on bone health.
File Format	HTM / HTML
ISSN	01492918
Issue Number	9
Volume Number	35
e-ISSN	1879114X
Journal	Clinical Therapeutics
Language	English
Publisher	Elsevier
Publisher Date	2013-09-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Pharmacology Bone Density Drug Effects Calcaneus Physiology Serotonin Uptake Inhibitors Adverse Effects Cross-sectional Studies Depression Drug Therapy Female Fractures, Bone Etiology Healthy Volunteers Humans Male Osteoporosis Chemically Induced Reproducibility Of Results Risk Factors Therapeutic Use Young Adult Journal Article
Content Type	Text
Resource Type	Article
Subject	Pharmacology Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The adverse skeletal effects of selective serotonin reuptake inhibitors.

The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults

Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.

Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia

Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men

Premenopausal Singaporean Women Suffering from Major Depressive Disorder Treated with Selective Serotonin Reuptake Inhibitors Had Similar Bone Mineral Density as Compared with Healthy Controls

The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review.

Selective serotonin-reuptake inhibitors and recovery after stroke.

Selective Serotonin Reuptake Inhibitors and Osteoporosis: Pathomechanism and Clinical Relevance Remain to Be Established

Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.

Similar Documents

The adverse skeletal effects of selective serotonin reuptake inhibitors.

The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults

Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.

Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia

Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men

Premenopausal Singaporean Women Suffering from Major Depressive Disorder Treated with Selective Serotonin Reuptake Inhibitors Had Similar Bone Mineral Density as Compared with Healthy Controls

The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review.

Selective serotonin-reuptake inhibitors and recovery after stroke.

Selective Serotonin Reuptake Inhibitors and Osteoporosis: Pathomechanism and Clinical Relevance Remain to Be Established

Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.